Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Che Odom
March 2 — Here's another reason to engage shareholders—it may help a board decide when to put a shareholder rights plan, also known as a “poison pill,” into action, an attorney said March 2.
“A lot of companies have shelf plans, but how do they know when to adopt them?” said Melissa Sawyer, a partner in the New York office of Sullivan & Cromwell LLP's mergers and acquisitions group, speaking at a Practising Law Institute event.
A shareholder rights plan, which can be adopted by the board without shareholder consent, is a strategy used by a corporation to discourage hostile takeovers by attempting to make its stock less attractive to a potential acquirer.
Institutional investors generally are against poison pills, but such shareholders may be a good source of information about stock trades, which is needed to decide when to implement a pill, Sawyer said.
A shelf plan is a shareholder rights plan that has been drafted and, ideally, discussed with a company's board but hasn't been signed, issued or publicly announced, Sawyer continued. It's “just sitting on the shelf.”
The decision to adopt the plan depends on tracking trades, which may be done best with the help of a proxy solicitor, which would monitor trading within custodians, and by talking with stockholders to understand whether they are buying or selling, Sawyer said. “If several of your largest investors indicate in those conversations that they are selling down their stake, then the next logical question is who's buying it and is it the same person accumulating a large stake all at once?”
Last year was a record-breaking one for mergers and acquisitions, and observers are predicting that the momentum will continue in 2016 (.
For example, JPMorgan's M&A Global Outlook said in February that solid economic growth over the last few years is boosting investor confidence in acquisitions. At the same time, growing cash reserves—about $6 trillion globally in the fourth quarter—has left potential buyers with plenty of power.
Meanwhile, Sawyer observed at the PLI event that proxy solicitors and shareholder engagement may be better, quicker ways of checking the pulse of trades than waiting for beneficial ownership reporting through Schedule 13D of the 1934 Securities Exchange Act or through the notifications of parties acquiring threshold amounts under the 1976 Hart-Scott-Rodino Antitrust Improvements Act.
“Traders can quickly buy large stakes in a company before they even hit the 13D 10-day disclosure window that would allow you to have insight into the size of their stake,” she said.
Under Hart-Scott-Rodino, a trader must buy about 78 million shares, which could be a much lower number than the 5-percent trigger under 13D, she said.
To contact the reporter on this story: Che Odom in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Yin Wilczek at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)